Classical and emerging infectious diseases, viral pandemics, and drug-resistant pathogens remain challenges to human health. However, contemporary advances in genetics and genomic technologies provide new approaches to understanding and combating these diseases. The American Society of Human Genetics (ASHG) and the Human Genome Organisation (HUGO) are partnering with Nature Publishing Group (NPG) to organize an international conference to discuss how the genomes, unique biologies, and interactions of both host and pathogen are being revealed using novel genomic technologies, and how this information can and will translate into disease management and therapies. This conference, from 21 to 24 March 2009, at the Ritz Carlton Millenia Hotel, Singapore, will engage basic and clinical scientists, including human geneticists, genome scientists, computational biologists, and experts in pathogenic microbial agents, to chart the effects of genomics on questions in global infectious disease management.
Organizers; Aravinda Chakravarti (American Society of Human Genetics, USA) ; Jeremy Farrar (Hospital for Tropical Diseases, Viet Nam) ; Louisa Flintoft (Nature Reviews Genetics, UK); Chris Gunter (HudsonAlpha Institute for Biotechnology, USA); Edison Liu (Human Genome Organisation, Singapore); and Magdalena Skipper (Nature, UK).